A recent study by Xu et al. reported that silencing of XIST inhibits lung cancer cell growth by allowing the transcription of p53 and NLR family pyrin domain containing 3 (NLRP3), which suppresses the function of SMAD2 to inhibit its translocation to the nucleus. The gene discussed is NLRP3; the disease is lung carcinoma.